Andrew Combs
Corporate Officer/Principal bei PRELUDE THERAPEUTICS INCORPORATED
Vermögen: - $ am 31.05.2024
Aktive Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Krishna Vaddi | M | 58 | 22 Jahre | |
| Bryant Lim | M | 53 | 6 Jahre | |
| Herve Hoppenot | M | 64 | 10 Jahre | |
| Paul Friedman | M | 81 |
DuPont Merck Pharmaceutical Co.
 DuPont Merck Pharmaceutical Co. Pharmaceuticals: MajorHealth Technology Part of Corteva, Inc., DuPont Merck Pharmaceutical Co. is a company that makes pharmaceuticals and drugs. The company is based in Wilmington, DE. DuPont Merck Pharmaceutical was acquired by EIDP, Inc., a subsidiary of Corteva, Inc. from Merck & Co., Inc. on July 01, 1998 for $2,600 million. | 13 Jahre |
| Aimee Crombie | M | - | 6 Jahre | |
| Victor Sandor | M | 57 | 14 Jahre | |
| Thomas Tray | M | 46 | 19 Jahre | |
| Jane Huang | M | 51 | 2 Jahre | |
| Peggy Scherle | M | 62 | 22 Jahre | |
| Julian Baker | M | 57 | 3 Jahre | |
| Martin Babler | M | 59 | 3 Jahre | |
| Jacqualyn Fouse | M | 62 | 7 Jahre | |
| Jean-Jacques Bienaimé | M | 70 | 9 Jahre | |
| David Bonita | M | 48 | 8 Jahre | |
| Paul Clancy | M | 62 | 9 Jahre | |
| Kimberly McCutcheon Jablonski | F | - | 21 Jahre | |
| Mardi Dier | F | 60 | 4 Jahre | |
| Catalina Loveman | F | - | 9 Jahre | |
| Vijay Iyengar | M | 51 | 8 Jahre | |
| Michael Morrissey | M | - | 8 Jahre | |
| Barry Flannelly | M | 66 | 10 Jahre | |
| Peter Langmuir | M | - | 9 Jahre | |
| Lothar H. Finke | M | - | 7 Jahre | |
| Madhu Pudipeddi | M | - | - | |
| Michele Porreca | F | - | 3 Jahre | |
| Wan-Jen Hong | M | 45 | - | |
| Steven Stein | M | 57 | 9 Jahre | |
| Lindsey Trickett | F | - | - |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Roy Whitfield | M | 70 | 23 Jahre | |
| Laurent Chardonnet | M | 59 | 3 Jahre | |
| Richard de Schutter | M | 83 |
DuPont Pharmaceuticals Co.
 DuPont Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology DuPont Pharmaceuticals Co. researches and develops pharmaceuticals and imaging products to treat diseases. It focuses on pharmaceuticals to treat unmet medical needs in the fight against HIV, cardiovascular disease, central nervous system disorders, cancer and arthritis-related disorders. The company is located in Wilmington, DE. | 14 Jahre |
| Robert Stein | M | 73 |
DuPont Merck Pharmaceutical Co.
DuPont Merck Pharmaceutical Co. Pharmaceuticals: MajorHealth Technology Part of Corteva, Inc., DuPont Merck Pharmaceutical Co. is a company that makes pharmaceuticals and drugs. The company is based in Wilmington, DE. DuPont Merck Pharmaceutical was acquired by EIDP, Inc., a subsidiary of Corteva, Inc. from Merck & Co., Inc. on July 01, 1998 for $2,600 million.
DuPont Pharmaceuticals Co.
DuPont Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology DuPont Pharmaceuticals Co. researches and develops pharmaceuticals and imaging products to treat diseases. It focuses on pharmaceuticals to treat unmet medical needs in the fight against HIV, cardiovascular disease, central nervous system disorders, cancer and arthritis-related disorders. The company is located in Wilmington, DE. | 7 Jahre |
| Richard Levy | M | 66 |
DuPont Pharmaceuticals Co.
DuPont Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology DuPont Pharmaceuticals Co. researches and develops pharmaceuticals and imaging products to treat diseases. It focuses on pharmaceuticals to treat unmet medical needs in the fight against HIV, cardiovascular disease, central nervous system disorders, cancer and arthritis-related disorders. The company is located in Wilmington, DE. | 19 Jahre |
| Reid Huber | M | 52 |
DuPont Pharmaceuticals Co.
DuPont Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology DuPont Pharmaceuticals Co. researches and develops pharmaceuticals and imaging products to treat diseases. It focuses on pharmaceuticals to treat unmet medical needs in the fight against HIV, cardiovascular disease, central nervous system disorders, cancer and arthritis-related disorders. The company is located in Wilmington, DE. | 20 Jahre |
| Steve Friedman | M | 78 |
DuPont Pharmaceuticals Co.
DuPont Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology DuPont Pharmaceuticals Co. researches and develops pharmaceuticals and imaging products to treat diseases. It focuses on pharmaceuticals to treat unmet medical needs in the fight against HIV, cardiovascular disease, central nervous system disorders, cancer and arthritis-related disorders. The company is located in Wilmington, DE.
DuPont Merck Pharmaceutical Co.
DuPont Merck Pharmaceutical Co. Pharmaceuticals: MajorHealth Technology Part of Corteva, Inc., DuPont Merck Pharmaceutical Co. is a company that makes pharmaceuticals and drugs. The company is based in Wilmington, DE. DuPont Merck Pharmaceutical was acquired by EIDP, Inc., a subsidiary of Corteva, Inc. from Merck & Co., Inc. on July 01, 1998 for $2,600 million. | 5 Jahre |
| Elias Bendekgey | M | 66 | 6 Jahre | |
| Osagie Imasogie | M | 62 |
DuPont Merck Pharmaceutical Co.
DuPont Merck Pharmaceutical Co. Pharmaceuticals: MajorHealth Technology Part of Corteva, Inc., DuPont Merck Pharmaceutical Co. is a company that makes pharmaceuticals and drugs. The company is based in Wilmington, DE. DuPont Merck Pharmaceutical was acquired by EIDP, Inc., a subsidiary of Corteva, Inc. from Merck & Co., Inc. on July 01, 1998 for $2,600 million. | 2 Jahre |
| David Hastings | M | 62 | 11 Jahre | |
| Barry Michael Ariko | M | 78 | 14 Jahre | |
| Scott W. Hurley | M | 65 | - | |
| Rosemary Crane | F | 64 | 20 Jahre | |
| Joseph Papa | M | 68 |
DuPont Pharmaceuticals Co.
DuPont Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology DuPont Pharmaceuticals Co. researches and develops pharmaceuticals and imaging products to treat diseases. It focuses on pharmaceuticals to treat unmet medical needs in the fight against HIV, cardiovascular disease, central nervous system disorders, cancer and arthritis-related disorders. The company is located in Wilmington, DE. | - |
| Paul S. Anderson | M | 85 |
DuPont Pharmaceuticals Co.
DuPont Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology DuPont Pharmaceuticals Co. researches and develops pharmaceuticals and imaging products to treat diseases. It focuses on pharmaceuticals to treat unmet medical needs in the fight against HIV, cardiovascular disease, central nervous system disorders, cancer and arthritis-related disorders. The company is located in Wilmington, DE. | 4 Jahre |
| Stacey L. Jurchison | F | - | 3 Jahre | |
| Eric Siegel | M | 60 | - | |
| Laurent Fischer | M | 60 |
DuPont Pharmaceuticals Co.
DuPont Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology DuPont Pharmaceuticals Co. researches and develops pharmaceuticals and imaging products to treat diseases. It focuses on pharmaceuticals to treat unmet medical needs in the fight against HIV, cardiovascular disease, central nervous system disorders, cancer and arthritis-related disorders. The company is located in Wilmington, DE.
DuPont Merck Pharmaceutical Co.
DuPont Merck Pharmaceutical Co. Pharmaceuticals: MajorHealth Technology Part of Corteva, Inc., DuPont Merck Pharmaceutical Co. is a company that makes pharmaceuticals and drugs. The company is based in Wilmington, DE. DuPont Merck Pharmaceutical was acquired by EIDP, Inc., a subsidiary of Corteva, Inc. from Merck & Co., Inc. on July 01, 1998 for $2,600 million. | 2 Jahre |
| Michael Charles A. Booth | M | 53 | 7 Jahre | |
| Rebecca Taub | M | 71 |
DuPont Pharmaceuticals Co.
DuPont Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology DuPont Pharmaceuticals Co. researches and develops pharmaceuticals and imaging products to treat diseases. It focuses on pharmaceuticals to treat unmet medical needs in the fight against HIV, cardiovascular disease, central nervous system disorders, cancer and arthritis-related disorders. The company is located in Wilmington, DE. | 3 Jahre |
| Paula Swain | F | 66 |
DuPont Pharmaceuticals Co.
DuPont Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology DuPont Pharmaceuticals Co. researches and develops pharmaceuticals and imaging products to treat diseases. It focuses on pharmaceuticals to treat unmet medical needs in the fight against HIV, cardiovascular disease, central nervous system disorders, cancer and arthritis-related disorders. The company is located in Wilmington, DE. | 10 Jahre |
| John F. Niblack | M | 85 | - | |
| Timothy Meeker | M | 77 | 13 Jahre | |
| Maria Pasquale | F | 58 | 5 Jahre | |
| Wenqing Yao | M | 61 |
DuPont Pharmaceuticals Co.
DuPont Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology DuPont Pharmaceuticals Co. researches and develops pharmaceuticals and imaging products to treat diseases. It focuses on pharmaceuticals to treat unmet medical needs in the fight against HIV, cardiovascular disease, central nervous system disorders, cancer and arthritis-related disorders. The company is located in Wilmington, DE. | 6 Jahre |
| Wendy Dixon | M | 68 | 12 Jahre | |
| Audrey F. Jakubowski | M | 81 |
DuPont Merck Pharmaceutical Co.
DuPont Merck Pharmaceutical Co. Pharmaceuticals: MajorHealth Technology Part of Corteva, Inc., DuPont Merck Pharmaceutical Co. is a company that makes pharmaceuticals and drugs. The company is based in Wilmington, DE. DuPont Merck Pharmaceutical was acquired by EIDP, Inc., a subsidiary of Corteva, Inc. from Merck & Co., Inc. on July 01, 1998 for $2,600 million. | 7 Jahre |
| Paul Trower | M | 54 | 18 Jahre | |
| Patricia A. Schreck | F | 70 | 8 Jahre | |
| David Spellmeyer | M | - |
DuPont Pharmaceuticals Co.
DuPont Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology DuPont Pharmaceuticals Co. researches and develops pharmaceuticals and imaging products to treat diseases. It focuses on pharmaceuticals to treat unmet medical needs in the fight against HIV, cardiovascular disease, central nervous system disorders, cancer and arthritis-related disorders. The company is located in Wilmington, DE. | 2 Jahre |
| Peter Nicklin | M | 61 | 14 Jahre | |
| Jin Jin Liang | M | 55 | 3 Jahre | |
| Georgia Keresty | M | 62 | 4 Jahre | |
| Enrique Sendagorta Gomendio | M | - | - | |
| Robert Roche | M | 57 | 6 Jahre | |
| James E. Foley | M | - | - | |
| Miguel Forte | M | 63 | 5 Jahre | |
| Arturo O. Araya | M | 53 | 3 Jahre | |
| Karen Smith | M | 56 | 5 Jahre | |
| Thomas J. McKearn | M | 75 | 10 Jahre | |
| Christopher Bowden | M | 63 | 3 Jahre | |
| Robert W. Morrissey | M | 66 | 6 Jahre | |
| Douglas C. Plessinger | M | 55 | 6 Jahre | |
| Paul Biondi | M | 54 | 13 Jahre | |
| Robert Martell | M | 61 | 3 Jahre | |
| Rajesh K. Malik | M | 65 | 2 Jahre | |
| Stéphane Thiroloix | M | - | - | |
| Kimberly A. Hendricks | F | 60 | 3 Jahre | |
| Beth Seidenberg | M | 67 | 2 Jahre | |
| Steven E. Benner | M | 64 | 7 Jahre | |
| Matthew Emmens | M | 72 | 3 Jahre | |
| John F. Bedard | M | 74 | - | |
| Fabio M. Benedetti | M | 58 | 3 Jahre | |
| Richard L. Wolgemuth | M | 78 | - | |
| David K. Bol | M | 58 | 6 Jahre | |
| Faheem Hasnain | M | 65 | 2 Jahre | |
| Bruce Wendel | M | 70 | 14 Jahre | |
| Michael A. Popson | M | - | 6 Jahre | |
| Andrew Shenker | M | 69 | 5 Jahre | |
| Roger Theodoredis | M | 65 | 3 Jahre | |
| Freda Lewis-Hall | M | 69 | 5 Jahre | |
| Daniel M. Bollag | M | 63 | 2 Jahre | |
| Andrew Bonfield | M | 61 | 5 Jahre | |
| Marino Carol | F | - | 8 Jahre | |
| William P. Keane | M | 68 | 1 Jahre | |
| David Apelian | M | 59 | 2 Jahre | |
| Alejandro A. Aruffo | M | 63 | 1 Jahre | |
| Hemanshu Shah | M | 63 | 14 Jahre | |
| Robert Hopfner | M | 51 |
DuPont Pharmaceuticals Co.
DuPont Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology DuPont Pharmaceuticals Co. researches and develops pharmaceuticals and imaging products to treat diseases. It focuses on pharmaceuticals to treat unmet medical needs in the fight against HIV, cardiovascular disease, central nervous system disorders, cancer and arthritis-related disorders. The company is located in Wilmington, DE. | - |
| Emma Reeve | F | 63 | 8 Jahre | |
| Dale Kummerle | M | - | 17 Jahre |
Statistik
| Land | Beziehungen | % des Gesamten |
|---|---|---|
| Vereinigte Staaten | 99 | 100,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Andrew Combs
- Persönliches Netzwerk
